Tissue expression
Cell line expression

MAGEA10

gene product
CT1.10, MAGE10, MGC10599 
This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the downstream melanoma antigen family A, 5 (MAGEA5) gene. [provided by RefSeq, Oct 2011]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antigen sequence

Epitope

Antibody

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
216 antibodies from 26 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Invitrogen Antibodies
9 antibodies
Abnova Corporation
6 antibodies
LifeSpan BioSciences, Inc.
31 antibodies
antibodies-online
81 antibodies
Proteintech Group
1 antibody
Cusabio Biotech Co., Ltd
7 antibodies
Cell Signaling Technology, Inc
2 antibodies
OriGene
4 antibodies
Biorbyt
10 antibodies
Aviva Systems Biology
4 antibodies
Acris Antibodies GmbH
2 antibodies
Abgent
1 antibody
Novus Biologicals
4 antibodies
Affinity Biosciences
1 antibody
Boster Biological Technology
1 antibody
NovoPro Bioscience Inc.
1 antibody
Wuhan Fine Biotech Co., Ltd.
1 antibody
St John's Laboratory
2 antibodies
Atlas Antibodies
2 antibodies
ProSci
2 antibodies
Abbexa
9 antibodies
MyBioSource
3 antibodies
United States Biological
12 antibodies
Creative Diagnostics
2 antibodies
MilliporeSigma / Merck KGaA
3 antibodies